FDMT Insider Trading Activity and SEC Form 4 Filings
FDMT insider trading summary
Over the past 12 months, insiders at 4D Molecular Therapeutics, Inc. (FDMT) reported 23 sales worth $5.1M by 3 insiders and no open-market purchases on SEC Form 4. Net insider selling was $5.1M.
Latest FDMT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Scott Bizily | Chief Legal Officer | Sell | $21K (1,635 @ $12.84) |
| Oct 5, 2026 | David Kirn | See Remarks | Sell | $4K (272 @ $13.61) |
| Oct 5, 2026 | David Kirn | See Remarks | Sell | $750K (58,061 @ $12.92) |
| Sep 16, 2026 | Scott Bizily | Chief Legal Officer | Sell | $22K (1,635 @ $13.65) |
| Sep 14, 2026 | David Kirn | See Remarks | Sell | $811K (58,333 @ $13.90) |
| Sep 1, 2026 | Scott Bizily | Chief Legal Officer | Sell | $8K (584 @ $14.00) |
| Aug 19, 2026 | David Kirn | See Remarks | Sell | $663K (43,149 @ $15.36) |
| Aug 19, 2026 | David Kirn | See Remarks | Sell | $426K (25,927 @ $16.42) |
| Aug 17, 2026 | Scott Bizily | Chief Legal Officer | Sell | $20K (1,635 @ $12.20) |
| Aug 13, 2026 | Scott Bizily | Chief Legal Officer | Sell | $20K (1,635 @ $12.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.